InvestorsHub Logo
Followers 0
Posts 107
Boards Moderated 0
Alias Born 03/07/2017

Re: None

Tuesday, 03/21/2017 1:55:29 PM

Tuesday, March 21, 2017 1:55:29 PM

Post# of 1317
Current Research Pipelne ~ Our acquisition in North America of two patent pending product formulations, cebidiofen and polyoxyfen, in partnership with Micro Medtech, Ltd. have entered a phase two, product development plan with Nutrasource Diagnostics, Inc. for medical foods that meet Generally Recognized As Safe (GRAS) regulatory standards; a pipeline process that is planned to complete in April 2017.

Source: http://healthadvanceinc.com